nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0981	0.0981	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0419	0.0419	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0405	0.0405	CbGpPWpGaD
Lapatinib—PIK3C2B—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.0382	0.0382	CbGpPWpGaD
Lapatinib—TAP1—Immune System—MB21D1—conduct disorder	0.0339	0.0339	CbGpPWpGaD
Lapatinib—TAP1—Direct p53 effectors—EP300—conduct disorder	0.027	0.027	CbGpPWpGaD
Lapatinib—TAP1—Immune System—POLR3A—conduct disorder	0.0249	0.0249	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—MB21D1—conduct disorder	0.0219	0.0219	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—MB21D1—conduct disorder	0.0215	0.0215	CbGpPWpGaD
Lapatinib—TAP1—Immune System—WASF1—conduct disorder	0.021	0.021	CbGpPWpGaD
Lapatinib—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0207	0.0207	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0193	0.0193	CbGpPWpGaD
Lapatinib—ERBB2—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.0192	0.0192	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—CGA—conduct disorder	0.0187	0.0187	CbGpPWpGaD
Lapatinib—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0183	0.0183	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—CGA—conduct disorder	0.018	0.018	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—POLR3A—conduct disorder	0.0161	0.0161	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—POLR3A—conduct disorder	0.0158	0.0158	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.0155	0.0155	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—WASF1—conduct disorder	0.0135	0.0135	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—WASF1—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MB21D1—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MB21D1—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Lapatinib—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0121	0.0121	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MB21D1—conduct disorder	0.0106	0.0106	CbGpPWpGaD
Lapatinib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Lapatinib—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00937	0.00937	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—POLR3A—conduct disorder	0.00935	0.00935	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—POLR3A—conduct disorder	0.00921	0.00921	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—COMT—conduct disorder	0.00842	0.00842	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—MAOA—conduct disorder	0.00836	0.00836	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—COMT—conduct disorder	0.00813	0.00813	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00811	0.00811	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—MAOA—conduct disorder	0.00808	0.00808	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00791	0.00791	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—WASF1—conduct disorder	0.00787	0.00787	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00783	0.00783	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—POLR3A—conduct disorder	0.00776	0.00776	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—WASF1—conduct disorder	0.00775	0.00775	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00752	0.00752	CbGpPWpGaD
Lapatinib—EGFR—Androgen receptor signaling pathway—EP300—conduct disorder	0.00704	0.00704	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00656	0.00656	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—WASF1—conduct disorder	0.00653	0.00653	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00648	0.00648	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00644	0.00644	CbGpPWpGaD
Lapatinib—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00639	0.00639	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CGA—conduct disorder	0.00635	0.00635	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CGA—conduct disorder	0.00626	0.00626	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MB21D1—conduct disorder	0.00616	0.00616	CbGpPWpGaD
Lapatinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00563	0.00563	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00561	0.00561	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00558	0.00558	CbGpPWpGaD
Lapatinib—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00554	0.00554	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CGA—conduct disorder	0.0052	0.0052	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—WASF1—conduct disorder	0.00509	0.00509	CbGpPWpGaD
Lapatinib—TAP1—Immune System—EP300—conduct disorder	0.00506	0.00506	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—WASF1—conduct disorder	0.00501	0.00501	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00501	0.00501	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00498	0.00498	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00494	0.00494	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—EP300—conduct disorder	0.0049	0.0049	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00478	0.00478	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00461	0.00461	CbGpPWpGaD
Lapatinib—EGFR—Immune System—POLR3A—conduct disorder	0.00452	0.00452	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00451	0.00451	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00426	0.00426	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00382	0.00382	CbGpPWpGaD
Lapatinib—EGFR—Immune System—WASF1—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00371	0.00371	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EP300—conduct disorder	0.0037	0.0037	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—EP300—conduct disorder	0.00361	0.00361	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—DRD4—conduct disorder	0.00356	0.00356	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—DRD4—conduct disorder	0.0035	0.0035	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—EP300—conduct disorder	0.00349	0.00349	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EP300—conduct disorder	0.00326	0.00326	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EP300—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CGA—conduct disorder	0.00307	0.00307	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00301	0.00301	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00299	0.00299	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—DRD4—conduct disorder	0.00291	0.00291	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WASF1—conduct disorder	0.00246	0.00246	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CGA—conduct disorder	0.00246	0.00246	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR2A—conduct disorder	0.00232	0.00232	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR2A—conduct disorder	0.00229	0.00229	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CGA—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00193	0.00193	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EP300—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR2A—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CGA—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EP300—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CGA—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—EP300—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EP300—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EP300—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DRD4—conduct disorder	0.00172	0.00172	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—EP300—conduct disorder	0.00158	0.00158	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EP300—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EP300—conduct disorder	0.00121	0.00121	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CGA—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2A—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—COMT—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MAOA—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—COMT—conduct disorder	0.00096	0.00096	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MAOA—conduct disorder	0.000953	0.000953	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000925	0.000925	CbGpPWpGaD
Lapatinib—EGFR—Immune System—EP300—conduct disorder	0.000919	0.000919	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—COMT—conduct disorder	0.000857	0.000857	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MAOA—conduct disorder	0.000851	0.000851	CbGpPWpGaD
Lapatinib—EGFR—Disease—EP300—conduct disorder	0.000849	0.000849	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—COMT—conduct disorder	0.000837	0.000837	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MAOA—conduct disorder	0.000831	0.000831	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000825	0.000825	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EP300—conduct disorder	0.000594	0.000594	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—COMT—conduct disorder	0.000515	0.000515	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MAOA—conduct disorder	0.000512	0.000512	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—EP300—conduct disorder	0.000475	0.000475	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—EP300—conduct disorder	0.000412	0.000412	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—EP300—conduct disorder	0.000368	0.000368	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—EP300—conduct disorder	0.000359	0.000359	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—EP300—conduct disorder	0.000221	0.000221	CbGpPWpGaD
